drugset / Trial / NCT05761002
Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts
NaSingle-groupOpen-labelTreatment
Summary
This study aims to investigate the relationship between HPV genotypes and treatment outcomes of intralesional immunotherapy of anogenital warts with the quadrivalent vaccine (Gardasil).
Timeline
- Start
- 2022-06-01
- Primary completion
- 2023-06-01
- Completion
- 2023-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gardasil | Vaccine | 0.5 ml | Intramuscular |